Quinoline as allosteric enhancers of the GABA-B receptors

Details for Australian Patent Application No. 2005300822 (hide)

Owner F. Hoffmann-La Roche AG

Inventors Malherbe, Parichehr; Norcross, Roger David; Thomas, Andrew William; Ratni, Hasane; Masciadri, Raffaello

Agent Spruson & Ferguson

Pub. Number AU-B-2005300822 (Modified Examination)

PCT Pub. Number WO2006/048146

Priority 04105429.7 01.11.04 EP

Filing date 25 October 2005

Wipo publication date 11 May 2006

Acceptance publication date 2 December 2010

International Classifications

C07D 215/18 (2006.01) Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

A61K 31/4738 (2006.01) - ortho- or peri-condensed with heterocyclic ring systems

A61P 25/22 (2006.01) Drugs for disorders of the nervous system

C07D 215/20 (2006.01) Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

C07D 215/38 (2006.01) Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

C07D 401/04 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 491/04 (2006.01) Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or

Event Publications

24 May 2007 PCT application entered the National Phase

  PCT publication WO2006/048146 Priority application(s): WO2006/048146

2 December 2010 Application Accepted

  Published as AU-B-2005300822 (Modified Examination)

31 March 2011 Standard Patent Sealed

24 May 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005300828-Dicarboxamide derivatives and their use as factor Xa inhibitors

2005300815-Acylated nonadepsipeptides used as lysobactin derivatives